Tardif G, Pelletier J P, Dupuis M, Geng C, Cloutier J M, Martel-Pelletier J
Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Arthritis Rheum. 1999 Jun;42(6):1147-58. doi: 10.1002/1529-0131(199906)42:6<1147::AID-ANR11>3.0.CO;2-Y.
We investigated the response of human osteoarthritic (OA) chondrocytes, in terms of collagenase 3 production, to growth factors and cytokines involved in the anabolism and catabolism of articular cartilage, and explored the major signaling pathways leading to its up-regulation.
Human OA chondrocytes were treated with the following factors: the proinflammatory cytokine interleukin-1beta (IL-1beta), the growth factors basic fibroblast growth factor (bFGF), platelet-derived growth factor BB (PDGF-BB), parathyroid hormone (PTH), insulin-like growth factor 1 (IGF-1), transforming growth factor gamma1 (TGFbeta1), and TGFbeta2, the protein kinase (PK) activator antagonists for PKC, PKA, and PKG pathways, and phospholipase A2 and tyrosine kinases, as well as the antiinflammatory cytokines IL-4, IL-10, and IL-13. Collagenase 3 expression and synthesis were determined. Comparison was made with collagenase 1.
The human OA chondrocyte population could be divided into 2 categories: the L chondrocytes, showing low collagenase 3 basal synthesis levels and high sensitivity to IL-1beta stimulation; and the H chondrocytes, high collagenase 3 basal synthesis levels and low IL-1beta inducibility. In L chondrocytes, all growth factors stimulated collagenase 3 production. In H chondrocytes, PTH, IGF-1, and TGFbeta had little or no impact; bFGF slightly stimulated it and PDGF-BB showed the same pattern as in the L chondrocytes. The effects of all growth factors, except TGFbeta, on collagenase 1 synthesis followed those of collagenase 3, albeit to a higher degree. Interestingly and unlike collagenase 3, the effects of TGFbeta on collagenase 1 could not be related to the state of the cells, but rather, depended on the isoform. Indeed, TGFbeta2 did not induce collagenase 1 synthesis, whereas TGFbeta1 stimulated it. Among the PK activators tested, phorbol myristate acetate was the strongest inducer, suggesting a major involvement of the PKC pathway. IL-13 inhibited collagenase 3 production, IL-4 had little effect, and IL-10 had none.
This study shows that collagenase 3 production in human OA chondrocytes depends on the physiologic state of the cell. TGFbeta might be responsible for the change in cells from the L to the H state. Importantly, our in vitro data implicate TGFbeta2 as a possible in vivo agent capable of specifically triggering collagenase 3 production over that of collagenase 1 in OA cartilage.
我们研究了人类骨关节炎(OA)软骨细胞在胶原酶3产生方面对参与关节软骨合成代谢和分解代谢的生长因子及细胞因子的反应,并探索了导致其上调的主要信号通路。
用以下因素处理人类OA软骨细胞:促炎细胞因子白细胞介素-1β(IL-1β)、生长因子碱性成纤维细胞生长因子(bFGF)、血小板衍生生长因子BB(PDGF-BB)、甲状旁腺激素(PTH)、胰岛素样生长因子1(IGF-1)、转化生长因子γ1(TGFβ1)和TGFβ2、蛋白激酶(PK)激活剂拮抗剂(针对PKC、PKA和PKG通路以及磷脂酶A2和酪氨酸激酶),以及抗炎细胞因子IL-4、IL-10和IL-13。测定胶原酶3的表达和合成。与胶原酶1进行比较。
人类OA软骨细胞群体可分为两类:L软骨细胞,胶原酶3基础合成水平低且对IL-1β刺激敏感;H软骨细胞,胶原酶3基础合成水平高且IL-1β诱导性低。在L软骨细胞中,所有生长因子均刺激胶原酶3的产生。在H软骨细胞中,PTH、IGF-1和TGFβ几乎没有影响或没有影响;bFGF有轻微刺激作用,PDGF-BB的作用模式与L软骨细胞相同。除TGFβ外,所有生长因子对胶原酶1合成的影响均与胶原酶3的影响一致,只是程度更高。有趣的是,与胶原酶3不同,TGFβ对胶原酶1的影响与细胞状态无关,而是取决于异构体。实际上,TGFβ2不诱导胶原酶1合成,而TGFβ1刺激其合成。在所测试的PK激活剂中,佛波酯是最强的诱导剂,表明PKC通路起主要作用。IL-13抑制胶原酶3的产生,IL-4影响不大,IL-10则无影响。
本研究表明,人类OA软骨细胞中胶原酶3的产生取决于细胞的生理状态。TGFβ可能是细胞从L状态转变为H状态的原因。重要的是,我们的体外数据表明TGFβ2可能是一种能够在体内特异性触发OA软骨中胶原酶3而非胶原酶1产生的因子。